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ABSTRACT
HMGB proteins are eukaryotic, chromatin-associated proteins that play roles in
both DNA dynamics and transcription regulation. Hmo1p is an HMGB protein in
Saccharomyces cerevisiae that behaves somewhat like a hybrid between mammalian
HMGB proteins and the metazoan linker histone H1. mTORC1, a protein complex
containing the Tor1p kinase and a major regulator of cellular growth, is inhibited by both
rapamycin and stress. It has also been shown to not only associate with Hmo1p at various
gene promoters, but also regulate the HMO1 gene itself through direct binding. In this
study, the Hmo1p-mTORC1 relationship was further investigated through two questions:
1) Does the transcription factor Sfp1p play a role in relaying mTORC1’s signal to the
HMO1 promoter, and 2) Is the reduction in HMO1 transcripts during stress dependent on
mTORC1? Gene expression analyses revealed that Sfp1p is not required for normal
HMO1 transcription; however, it does appear to play a role in transmitting the mTORC1
stress signal to the promoter, as transcripts are only significantly decreased during stress
when Sfp1p is present. Survival tests revealed that Sfp1p might be hindering the cell’s
ability to repair DNA double-strand breaks, as there is a slight increase in cell survival
during double-strand break-induction when Sfp1p is knocked-out; however, there is some
uncertainty as to whether this is Hmo1p-related. Chromatin Immunoprecipitation
techniques were then used to demonstrate that RNA polymerase II is evicted from the
HMO1 gene over the course of one hour during stress when Tor1p is knocked-out. This
same phenomenon had previously been shown in wild-type cells; however, HMO1
transcripts are only attenuated in wild-type cells, and not when Tor1p is knocked-out. This
suggests that mTORC1 is responsible for the reduction of HMO1 mRNA during stress.
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We propose the possibility that mTORC1 is participating in active mRNA degradation at
the HMO1 gene, and that transcription-inhibition techniques can be utilized to confirm
this.
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CHAPTER 1. INTRODUCTION AND BACKGROUND
1.1. Chromatin
The genetic material of eukaryotic organisms is comprised of DNA compacted into
higher-order structures by means of nucleoprotein complexes, thus forming chromatin
(1,2,3). These complexes, the nucleosomes, consist of approximately 146 DNA base
pairs wrapped 1.7 times around 2 copies each of H2A, H2B, H3, and H4, altogether
forming a histone octamer (1,2). Each H2A and H2B histone are dimerized, forming two
H2A/H2B heterodimers, while the H3 and H4 histones collectively form a (H3/H4)2
heterotetramer (2). The negatively-charged phosphodiester backbone of the DNA is
attracted to the positively charged amino acid residues (notably those of lysine and
arginine) that are common in histone core particles, creating a first-order compaction of
chromatin known as the 11-nanometer (nm) “beads on a string” (26). In this conformation,
the N-terminal tails of each histone jut out from the nucleosome and contact neighboring
chromatin proteins as a means of regulating higher-order structures (21).
Linker DNA connects adjacent nucleosomes and may be bound by linker histones.
Metazoan cells contain the linker histone H1, which is localized to where linker DNA
enters/exits the nucleosome (1). H1 allows the “beads on a string” to further compact by
means of its lysine-rich C-terminus as well as its globular “winged-helix-turn-helix” domain
(1). This causes the DNA to coil into a 30-nm fiber (secondary structure), which can further
compact into still higher order (tertiary) structures depending on the stage of the cell cycle.
Chromatin itself can be classified as being in one of two states: heterochromatin or
euchromatin. Heterochromatin is heavily supercoiled and highly condensed, preventing
the access of RNA polymerases and transcription factors, rendering it transcriptionally-
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inactive (21). Its dense nature allows it to resist nuclease activity, providing some means
of protection (25). On the other hand, euchromatin is accessible to gene expression
proteins due to its relatively loose coiling and unpacked nature. Therefore, euchromatin
is generally transcriptionally-active (21).
Histones can be modified through the attachment of several different possible
functional groups, which can affect the heterochromatin-euchromatin dynamics. Among
the more commonly detected modifications are the acetylation of lysine residues’ ϵ-amino
groups. The negative charge of the DNA phosphodiester backbone makes it highly
attracted to positively charged side chains, such as lysine; therefore, the neutralization of
these side chains would attenuate the interactions between the two. The addition of acetyl
groups via histone acetyltransferases (HATs) does exactly that, and this is generally
accompanied by an increase in gene transcription. This process is reversed via histone
deacetylases (HDACs), and the coordination of these two enzymes helps regulate the
transcriptional output of affected genes. In addition, the acetylated lysines of histones
serve as binding sites for certain binding-domains, such as PHD fingers and
bromodomains. For example, the SWI/SNF remodeling complex, which opens the DNA
around the nucleosome core, uses the bromodomain of Swi2/Snf2 to recognize
acetylated lysines (9).
In addition to acetylation, methylation of histones has been shown to affect
transcription regulation, albeit by a different mechanism. Rather than altering chromatin
dynamics, the addition of methyl groups to lysine and arginine residues has been shown
to recruit specific proteins that perform specific functions (9). Histone methylation has also
been shown to play a role in regulating the cell cycle during DNA repair as well as RNA
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interference (10). Another type of histone modification, phosphorylation, has been shown
to be important in various DNA-related processes, including the regulation of gene
expression, particularly of proliferative genes. There is also a significant connection
between histone phosphorylation and chromatin compaction associated with mitosis and
meiosis (11).
Of particular note, however, is the role of histone phosphorylation in DNA repair
processes. DNA double-strand breaks (DSBs) are cuts in the phosphodiester backbones
of both DNA strands at a complementary location, which thereby sheer a single doublestrand DNA molecule into two. In mammalian cells, if left unaided for too long, these DSBs
can prove detrimental to cellular health by promoting cancer and other diseases.
Therefore, when DSBs occur, the cell responds by generating a sequence of events,
known as the DNA-damage response, in order to repair the damage. In order for DNA
repair to occur, however, chromatin remodeling must take place to allow repair proteins
to access the damage site. Histone phosphorylation is one of the earliest steps in this
process, taking place on H2A at serine-129 in yeast and on H2AX (an H2A variant) at
serine-139 in mammals, thereby generating -H2AX. This phosphorylation is the initial
step in activating homologous recombination, non-homologous end joining, and other
DNA-damage responses (2,3,8,11,12).
1.2. Saccharomyces cerevisiae
The budding yeast Saccharomyces cerevisiae, commonly known as baker’s yeast
(hereafter simply referred to as “yeast”), is a unicellular fungus [1] that is regularly used
as a laboratory model organism, due to its relatively fast life cycle and the evolutionary
conservation of several of its genes and molecular pathways. The life cycle of yeast
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consists of both haploid and diploid stages, depending on environmental factors. In the
haploid stage, its DNA is compacted into 16 nuclear chromosomes (22) that altogether
form a genome approximately 24 Mbp in length (23). In this stage, yeast reproduces
through budding of a new daughter cell from the parent cell, ultimately leading to nuclear
mitosis and the separation of the bud to form a new diploid cell. During environmental
stress, diploid cells begin the process of sporulation by means of meiosis. The cell then
becomes an ascus, forming four spores within itself before its wall breaks down (24).
The spores are the yeast haploid cells, each one containing a copy of the MatingType Locus (MAT). Cell mating-types are distinguished through two non-homologous
alleles, designated as “a” and “α”. Depending on its mating-type, each haploid cell
produces one of two types of pheromones: the 13 amino acid a-factor or the 12 amino
acid α-factor. Special receptors recognize the pheromone of the cell’s opposite matingtype, and the cell cycle is arrested at G1. Proteins essential for the mating process are
synthesized in each cell, and an extension of each cell’s plasma membrane (and cell wall)
grow toward the targeted mate (24). These “shmoos” meet at their projections, where
they fuse their cytoplasms to form a single cell (27). Afterward, karyogamy, or nuclear
fusion, occurs, generating a diploid zygote (MATa/α) and completing the life cycle (24).
In addition to MAT, yeast cells contain the transcriptionally-silent loci denoted as
HMRa and HMLα that contain the genetic information for expression of the “a” and “α”
phenotypes, respectively. Silent information regulator (SIR) genes prevent these loci from
being expressed. However, their information can be copied to MAT via duplicative
transposition in order to switch the mating-type of the cell. This process is initiated by the
HO (homothallic) gene, which encodes the HO endonuclease, a site-specific protein that
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targets an 18 bp sequence in the MAT locus and generates a DSB (24) with sticky ends
(28). DSB repair mechanisms delete the mating-type cassette in MAT, after which it is
repaired through the replication of the opposite mating-type cassette within its locus (24).
This mechanism can be exploited for experimental purposes to test the effects of DSBs
in yeast (Figure 1).

Figure 1. Mechanism of Controlled Induction of DSBs. A plasmid encoding HO under
control of the GAL1 promoter is transformed into yeast and galactose is supplied as a
carbon source in order to activate the promoter and induce transcription of HO
endonuclease. The endonuclease then targets the MAT locus and creates a DSB. As the
target site of HO endonuclease is specific, this provides a means of experimental control,
preventing the DSB from occurring at random sites, which would potentially damage
essential genes.
Yeast also contains a special linker histone called Hho1p, which is distinguished
from metazoan H1 by its possession of two globular domains. One of these domains is
very similar to that of H1, suggesting homology between the two proteins. In yeast, this
domain, which adopts a similar fold to that of H1, has been shown to protect against
nuclease activity by means of nucleosome-binding (2,8). Hho1p’s second globular
domain, which is unstructured in neutral conditions and adopts a winged-helix motif in the
5

presence of concentrated tetrahedral anions, binds most efficiently to DNA four-way
junctions (2). During stationary phase, Hho1p assists in genomic compaction by forming
loops along the length of the nuclear DNA, further linking it to metazoan H1 functions.
Unlike H1, however, Hho1p does not contain a basic C-terminus; rather, its lysine-rich
domain is enclosed between its two globular domains, preventing it from participating in
chromatin reorganization (2,8). In addition, the stoichiometry of Hho1p to nucleosomes in
yeast is significantly lower than that of its metazoan counterpart (2).
1.3. The High-Mobility Group Box Protein Hmo1p
High-mobility group box (HMGB) proteins are eukaryotic nuclear proteins that are
highly involved in DNA-dependent processes. They are typically defined by their “HMGBox” domains (2,3,8), which consist of three α-helices that are arranged in an L-shaped
motif that plays significant roles in DNA interactions (2). There are two categories of
HMGB proteins: sequence-specific and non-sequence-specific. By definition, sequencespecific HMGB proteins are specialized transcription factors, only being expressed in
specific cell types. In contrast, non-sequence-specific HMGB proteins are common to all
eukaryotic cells and play a major role in chromatin dynamics. They are considered
“architectural” by definition, as their HMG-Box domains act to bind/bend DNA targets. As
a consequence of this, they tend to display a high affinity to pre-bent DNA. DNA-bending
via HMGB proteins is accomplished through the energy derived from the electrostatic and
van der Waals interactions made between the HMG-Box domain and the DNA minor
groove. As the minor groove widens due to the insertion of the HMG-Box, the major
groove narrows, generating a bend in the overall structure (2).
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Non-sequence-specific HMGB proteins usually contain two HMG-Box domains
(Box A and Box B) that have higher affinity for non-B-form DNA, including four-way
junctions, somewhat linking their functionality to Hho1p. In mammals, HMGB proteins 14 contain acidic C-termini, which interact with Box A and Box B to block them from being
able to bind to DNA. In the case of nucleosomes, however, it is believed that the Nterminus of histone H3, which contacts linker DNA by passing through the DNA entry-exit
point, interacts with the acidic C-terminus to allow the binding of the box domains to the
entry-exit point, distorting the nearby DNA. In turn, this creates a chain reaction of DNAunwinding around the nucleosome core, generating a loosely-packed chromatin
environment associated with transcriptional activation. As a result, mammalian HMGB
proteins engage in competitive nucleosome-binding against the linker histone H1, leading
to dynamic chromatin-regulation methods (2,8).
Of the many HMGB proteins found in yeast, Hmo1p and Hmo2p are notable as
having two separate globular domains that heavily resemble HMG-Boxes (hereafter
referred to as Box A and Box B) (2). Hmo1p, in particular, has been found to not only
possess HMGB characteristics, but also those of linker histones, due in part to its lysinerich C-terminus. Along with its terminal domain, Hmo1p’s Box A and Box B domains
further contribute to chromatin compaction (2,3,8,14). Box A domains dimerize in order
to bend Hmo1p-bound DNA (2,14), and although it has low affinity for B-form DNA, it
possesses structural specificity for other forms, particularly four-way junctions (similar to
HMGB proteins and Hho1p) (2). Box B, on the other hand, is mostly responsible for the
protein’s overall DNA-binding affinity, and it does not directly play a role in DNA bending
(2,14).
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Two models of Hmo1p-mediated DNA stabilization have been proposed. The first,
as mentioned above, involves the dimerization of Hmo1p’s Box A domains, which
happens particularly in nucleosome-free DNA. The second, which occurs at the
nucleosome dyad when it is bound by Box A, involves the lysine-rich C-terminus
preventing DNA unwinding around the nucleosome through its association with the linker
DNA. This particular characteristic contrasts Hmo1p with typical mammalian HMGB
proteins, which typically bind to nucleosome dyads to loosen the DNA (2). Hmo1p has
been shown to localize to the MAT locus, and of particular interest is its tendency to
become evicted following 2 hours of continuous DSBs (3,5,8). This provides a simple
means of control while performing experiments relating to DSBs. In addition to DNA
compaction, Hmo1p has been shown to be involved in transcriptional activity, particularly
at the promoters of ribosomal biogenesis (Ribi) genes, various ribosomal protein (RP)
genes, and even the HMO1 gene itself (2,3,8,5,14).
Due to its ability to stabilize chromatin, Hmo1p has a significant effect on DNA
repair efficiency. It has been demonstrated that in the absence of Hmo1p, cell survival is
significantly increased during continuous DSBs. It is believed that when chromatin is
heavily compacted by Hmo1p, DNA repair proteins have a more difficult time accessing
the DSB sites. Thus, a less-condensed chromatin environment would allow for a greater
chance of DNA-damage repair and, therefore, continued cell survival (2,3,8)
1.4. The Target of Rapamycin Complex 1 (TORC1)
In order for cells to carry out a response to a particular stimulus, specialized
proteins must relay the signal within the cell. Protein kinases accomplish this by
phosphorylating downstream targets, such as proteins targeted to gene promoters or
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other cellular proteins. The yeast serine-threonine kinase TORC1 (target of rapamycin
complex 1), a multi-protein complex containing the catalytic Tor1p (5,20) is a significant
regulator of cellular development, playing roles in the expression of ribosome-related
genes (2,5,14,16,17,18,20) as well as various RNA polymerase II (Pol ll)-transcribed
genes (5,17,18). rRNA genes are regulated by TORC1 through direct contact (2,5), while
RP and Ribi genes are regulated indirectly via downstream phosphorylation targets, such
as the AGC family protein kinase Sch9p (2,5,9) and the zinc-finger transcription factor
split finger protein 1 (Sfp1p). Sfp1p itself has been shown to be required for maximal
ribosome production in yeast, which makes sense in context with its tendency to bind to
RP promoters (2,5,17,18,19). Furthermore, Sfp1p’s overall localization within the cell
appears to be dependent on TORC1: while TORC1 is inactive, Sfp1p remains in the
cytoplasm, hindering it from participating in gene regulation. Its localization to the nucleus
is reserved for instances of TORC1 activation (2,5,18,19).
Several different proteins make up the overall complex of TORC1. In yeast, these
subunits are called Tor1p (or possibly Tor2p), Kog1p, Tco89p, and Lst8p (5,13,20). In
mammalian cells, the complex, originally referred to as mammalian TORC1, contains a
specific mammalian TOR (mTOR) protein along with the regulatory-associated protein of
mTOR (RAPTOR), mLst8, the proline-rich Akt substrate of 40 kDa (PRAS40), and the
disheveled, Egl-10, and Pleckstrin domain-containing mTOR-interacting protein
(DEPTOR). RAPTOR is the ortholog of Kog1p, while PRAS40 and DEPTOR take the
place of Tco89p (13,20). The catalytic subunits, Tor1p/Tor2p and mTOR, are
phosphatidylinositol kinase-related kinases (PIKKs). In yeast, both Tor1p and Tor2p can
act as the catalytic subunit due to their similar domains (5,13,20).
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TORC1 has been heavily conserved throughout evolution from yeast to mammals,
making it a commonality among eukaryotes under the collective name “mechanistic
TORC1” (hereby referred to as “mTORC1”) (5,13,20). As its name implies, mTORC1 is
inhibited by the Streptomyces hygroscopicus-produced macrolide rapamycin, which
binds to the 12-kDa FK506-binding protein (FKBP12). This complex gains the ability to
block the Tor1p/Tor2p active site by binding to its FKBP-rapamycin-binding (FRB)
domain, thus inhibiting catalytic potential (13,20). It has further been demonstrated that
cellular stress (DSBs in particular) mimics this inhibition response (5). In regards to
HMO1, mTORC1 is responsible for relaying the stress signal to the promoter, as a
decrease in HMO1 transcript levels is only observed after induction of DSBs when Tor1p
is present (5). This was surprising, considering how Tor2p has been shown to take the
place of Tor1p as the catalytic subunit when necessary. This suggested that Tor1p had a
more specific function in regulating the HMO1 promoter; in particular, Tor1p may be
localizing

to

the

promoter

and

performing

some

direct

activity.

Chromatin

immunoprecipitation (ChIP) techniques have confirmed that it binds directly to the HMO1
promoter (5), and while a similar behavior has been demonstrated at other genes
(including the aforementioned rRNA genes), its role in binding to this particular promoter
is currently unknown.
Pol ll eviction throughout the HMO1 gene has been shown to occur within 1 hour
of DSB induction in wild-type (WT) yeast cells (5), providing what was once a possible
explanation for the accompanied decrease in transcript levels. However, preliminary data
has suggested a similar phenomenon in tor cells (Ashish Gupta, unpublished data),
where DSBs have been shown to have no effect on HMO1 transcript levels. The
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observation that HMO1 transcript levels do not decrease in response to DNA damage
when Tor1p is absent, even though Pol ll leaves the gene, indicates that mTORC1 is
somehow responsible for the response. As such, this may be a key piece of evidence for
explaining why mTORC1 binds to particular genes.
The relationship between Hmo1p and mTORC1 has been of particular interest in
our lab; therefore, my aim was to further study this relationship in regards to DNA damage.
With evidence suggesting that Sfp1p may also be involved in this interaction, I first looked
into the possibility of Sfp1p’s involvement in HMO1 regulation via mTORC1 signaling by
conducting both survival and gene expression analysis experiments. I then sought to
determine the precise role of mTORC1-binding at the HMO1 gene by demonstrating Pol
ll eviction from the locus during DSB.
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CHAPTER 2. MATERIALS AND METHODS
2.1. Gene Expression Analysis
Cultures of two Saccharomyces cerevisiae strains, DDY3 (our experimental WT)
and DDY3-sfp1, were grown in synthetic minimal uracil-dropout (-URA) media and
tryptophan-dropout (-TRP) media, respectively, at 30C with constant shaking to
exponential phase (OD600~0.4-0.8). Both strains had previously been transformed with
a plasmid encoding HO endonuclease under control of the GAL1 promoter and marker
genes for uracil (DDY3) and tryptophan (DDY3-sfp1) (See 5). Both were supplemented
with raffinose as a carbon source (2% final concentration). 15 mL of culture were pelleted
and washed with diethyl pyrocarbonate (DEPC)-treated water (0-hour control). The
remaining culture was then treated with galactose (2% final concentration) and incubated
at room temperature for 1 hour with constant shaking, after which 15 mL were pelleted
and washed with DEPC-treated water. Pellets were stored at -80C overnight.
Pellets were thawed and total RNA was extracted via illustra RNAspin Mini RNA
Isolation Kit (GE Healthcare), after which TURBO DNase (Ambion) was used to degrade
contaminating genomic DNA. PCR was used to confirm complete removal of DNA.
NanoDrop (Thermo Scientific) was used to determine total RNA concentrations and
dilutions

were

made.

1

µL

of

20

mM

reverse

primer

(5’-

TCTCCAACTCGACGTTGTAAGCCTGC-3’) was added to ~100 ng of total RNA in a
separate 1.5 mL Eppendorf tube and sterile ddH2O was added to make the total volume
13 µL. Samples were incubated at 65C for 5 minutes and then placed on ice for 5 minutes
to allow primer annealing and fixation. AMV Reverse Transcriptase (New England
Biolabs) was used to generate cDNA. 2 µL 25 mM magnesium chloride, 2 µL 25 mM
12

dNTPs, 2 µL 10x AMV Reverse Transcriptase Reaction Buffer, and 1 µL AMV Reverse
Transcriptase (10,000 units/mL) were added to make a 20 µL reaction volume. The entire
mixture was placed in a 42C water bath for 1 hour, and resulting samples were stored at
-20C. cDNA was verified using PCR.
For quantitative-PCR (qPCR), samples were prepared in triplicate, 20 µL reactions
in a 96-well plate using Luna Universal qPCR Master Mix (New England Biolabs). Primer
sequences

used

for

the

reading

open

frame

(ORF)

were

5’-

AAGATAGAGGCTTTCACCACTTTGAC-3’ (forward) and the aforementioned cDNAgenerating primer (reverse). A QuantStudio 6 Flex Real-Time PCR System (Applied
Biosystems) was used to carry out qPCR. The IPP1 gene was used as a reference
(primers:

5’-CCCAATCATCCAAGACACCAAGAAGG-3’

[forward],

5’-

AGCAATAGTTTCACCAATTTCCAACACATC-3’ [reverse]). Relative expression levels
were calculated via the Ct method.
2.2. Survival Tests
The aforementioned strains were both grown to exponential phase (OD 600~0.50.8) and treated with galactose as described above. 1 mL of culture was collected prior
to treatment and every hour thereafter for up to 4 hours and diluted to 1000x, after which
50 µL were plated on either synthetic minimal -URA or -TRP agar media with raffinose
(2% final concentration) and incubated at 30C for 2-5 days. Colonies were counted and
used to determine the concentration of the treated, undiluted sample through the following
equation: (# of Colonies * 1000µL * 1000x) / (50µL * OD600)
2.3. Chromatin Immunoprecipitation
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ChIP was performed using the same protocol as described in (5) with the following
alterations. Cultures of DDY3-tor1 containing the aforementioned HO/uracil marker
plasmid were grown in synthetic minimal -URA media with raffinose (2% final
concentration) in 30C with constant shaking to exponential phase (OD600~0.5-0.8). A 50
mL sample of culture (0-hour control) was collected and treated with formaldehyde (3%
final concentration) and left to shake at room temperature for 20 minutes to allow DNAprotein crosslinking, after which the sample was pelleted and washed with 1x phosphatebuffered saline (PBS). The remaining culture was treated with galactose (2% final
concentration) to induce DSBs and incubated at room temperature for 1 hour with
constant shaking. 50 mL samples were collected at 15, 30, and 60 minutes, treated with
formaldehyde as described above, pelleted, and washed with 1x PBS. Pellets were stored
at -80C overnight.
ChIP lysis buffer (50 mM HEPES [pH 7.5], 140 mM NaCl, 1% Triton X-100, 0.1%
sodium deoxycholate) with protease inhibitor was prepared using one tablet of Roche
cOmplete protease inhibitor cocktail (mini, EDTA-free) dissolved in 1.5 mL sterile ddH2O,
which was then added at 10 µL/mL lysis buffer (mixture hereby referred to as PI). 400 µL
PI was added to each thawed pellet along with 500 µL of acid-washed glass beads (~500
µm) and left to vortex in 1.5 mL Eppendorf tubes at 4C for 40 minutes. 10 µL 100 mM
phenylmethylsulfonyl fluoride (PMSF) dissolved in isopropanol was added to each
sample, and flame-heated 26G syringe needles were used to poke through the bottoms
of the tubes, after which each pierced tube was placed within a second tube and briefly
centrifuged to allow the total cell extract to filter through. Samples were sonicated for 10
seconds (0.9 ON, 0.1 OFF) at 25% amplitude a total of 6 times while being left on ice for
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1 minute between sonications. Remaining cell debris was removed through
centrifugation, and 10 µL PMSF was added. 20 µL of the resulting whole-cell extract
(WCE) was used to check for chromatin fragment size, while the rest was stored in -80C.
The 20 µL WCE was added to 200 µL of immunoprecipitation elution buffer (IPEB)
(100 µL 1 M NaHCO3, 50 µL 20% SDS, 850 µL sterile ddH2O) and 10 µL 5M NaCl, and
the total mixture was incubated at 65C for 4 hours to reverse crosslinking.
Phenol/chloroform was used to extract DNA, and RNase A (final volume 60 µg/mL) was
used to remove total RNA in 25 µL 1x TE at 37C for 30 minutes. Samples were run on
1% agarose gels to determine fragment sizes (target size: 300-1000 bp).
Protein G-Sepharose 4 Fast Flow (GE Healthcare) beads were prepared by taking
35 µL of beads per sample (including antibody immunoprecipitation [AIP] and no antibody
control [NA]) and washing them with PI (105 µL per sample) 3 times via centrifugation
(8000 RPM, 3 minutes). Bead resuspension buffer (2.4 mL PI, 88 µL salmon sperm DNA
[200 µg/mL], and 120 µL bovine serum albumin [500 µg/mL]) was used to dilute beads
back up to their original volume (35 µL per sample). For each sample, 100 µL WCE was
mixed with 300 µL PI and 30 µL beads and left to rock on a nutator for 1 hour at 4 C for
preclearing. Beads were then removed via centrifugation and 2 µL anti-RNA polymerase
II CTD was added to each AIP sample. AIP and NA samples were then left to rock on a
nutator at 4C for 10 hours, and after the addition of 30 µL prepared beads, samples were
left to rock for another 12 hours.
Beads were separated from solution via centrifugation and washed for 15 minutes
using lysis buffer via rocking on nutator at 4C. Centrifugation was used to separate
beads, and process was repeated using IP wash buffer 1 (lysis buffer, 500 mM NaCl, filter
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sterilized), IP wash buffer 2 (10 mM Tris [pH 8], 250 mM LiCl, 0.5% NP-40, 0.5% sodium
deoxycholate, 1 mM EDTA, filter sterilized), and 1x TE (twice). After removing second TE,
each sample was treated with 250 µL IPEB and shaken at 150 RPM at room temperature
to elute crosslinked protein-DNA from beads. Samples were centrifuged and 225 µL of
the resulting supernatant of crosslinked protein-DNA was transferred to a separate
sterilized Eppendorf tube. The process was repeated with the left-over beads and the
supernatant added to the first collection. 100 µL of remaining WCE per sample was
thawed and mixed with 475 µL IPEB and 20 µL 5 M NaCl, acting as the input control (IC).
Each bead-eluted sample was also treated with 20 µL 5 M NaCl, and all samples were
subjected to 65C incubation for 4 hours to undo formaldehyde crosslinking. All samples
were then treated with 20 µL 1 M Tris (pH 8), 10 µL 0.5 EDTA, and 1 µL Proteinase K
and left to incubate at 55C for 30 minutes. Phenol/chloroform extraction was used to
remove remaining protein, and DNA was collected using ethanol precipitation. DNA was
resuspended in 200 µL 1x TE and treated with RNase A (final volume 60 µg/mL) at 37C
for 30 minutes. PCR was performed using 17.8 µL sterile ddH 2O, 1 µL Taq DNA
Polymerase with 3 µL Standard Taq Buffer (New England Biolabs), 1 µL each of the
aforementioned ORF 20 mM forward and reverse primers, 0.6 µL 25 mM dNTPs, and 3
µL 25 mM magnesium chloride (27.4 µL reaction). Samples were run on a 1% agarose
gel, and ImageJ imaging software was used to quantify band intensities. IC and NA bands
were used to standardize AIP bands.

16

CHAPTER 3. RESULTS AND DISCUSSION
3.1. Sfp1p is Involved in Regulating the HMO1 Promoter
Based on the idea that DNA damage inhibits mTORC1 signaling, our lab has
previously shown that DNA damage reduces HMO1 transcript levels, but only when Tor1p
is present, indicating that mTORC1 is involved in transmitting the stress signal to the
promoter (5). As mentioned above, we had reason to believe that Sfp1p may be involved
in HMO1 promoter regulation, and that inducing DSBs may have a different effect on
transcript levels depending on whether Sfp1p was present or not. We used WT and sfp1
strains containing plasmids encoding the HO endonuclease under control of the GAL1
promoter to induce DSBs by adding galactose as a carbon source. Total RNA was
extracted from cells and subjected to qPCR to measure Ct values. to Using the Ct
method, it was determined that Sfp1p does not have a significant effect on HMO1
expression in the absence of DSBs, indicating that Sfp1p is not involved in normal HMO1
expression during exponential growth (Figure 2A). However, after inducing DSBs, it was
clear that Sfp1p is somehow involved in relaying the stress signal to the promoter, as
expression levels fail to go down in a sfp1 strain (Figures 2B and 2C). Thus, there is a
similar response to DSBs between tor1 and sfp1 cells, indicating that the two proteins
may be interacting at the promoter. This makes sense in context with Sfp1p’s role as a
downstream phosphorylation target for mTORC1 at RP gene promoters, and this further
emphasizes a similarity in gene regulation between RP genes and other Pol ll-transcribed
genes (in this case, HMO1).
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Figure 2. Sfp1p’s Effects on HMO1 Transcription. (A) Bar graph representing relative
HMO1 transcript levels between WT and sfp1 during exponential growth. (B) Bar graph
representing relative WT HMO1 transcript levels between untreated samples (WT 0) and
samples that have undergone 1 hour of DSB induction via galactose-mediated expression
of HO endonuclease (WT 1). (C) Bar graph representing relative sfp1 HMO1 transcript
levels between untreated samples (sfp1 0) and samples that have undergone 1 hour of
DSB induction via galactose (sfp1 1). IPP1 was used as a reference gene. Expression
values normalized to untreated (0 Hr) cells. Means and standard deviations are
representative of 3 replicates.
It is worth noting that cells were pelleted at a wide range of concentrations.
Theoretically speaking, gene expression should remain relatively constant throughout all
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of the exponential growth phase, as was the reasoning during this experiment. While this
appears to hold true in WT, the sfp1 fold changes have exceptionally wide error bars
around their means, indicating the likelihood of more concentration-sensitive transcription
regulation. What we can conclude from this data is that Sfp1p is having some sort of effect
on HMO1 transcription during DSBs, likely acting as a signaling mediator between
mTORC1 and the promoter.
Based on the idea that Hmo1p stabilizes chromatin and its absence results in more
efficient DNA repair, we wanted to test the possibility that Sfp1p made a difference in cell
survival during consistent DSBs. Based on the aforementioned gene expression data, it
could be predicted that in a sfp1 strain, cell survival would be similar to that of WT, as
the mTORC1 stress signal would fail to reach the HMO1 promoter, thus permitting
standard cellular levels of Hmo1p. Considering how Hmo1p remains at the MAT locus for
2 hours of DSBs, we first wanted to test if the absence of Sfp1p changed this behavior.
WT and sfp1 cultures containing the GAL1-HO plasmid were grown to exponential
phase and treated with galactose to induce expression of the HO endonuclease in order
to generate DSBs, after which cells were diluted, plated, and incubated at 30C for several
days. WT and sfp1 cells that were subjected to 2 hours of DSBs before being plated
showed no significant difference in survival (Data not shown), prompting us to extend
DSB treatment to 4 hours. Conducting 4-hour survival tests in WT revealed expected
results, as judging simply by the generated error bars, cell survival clearly decreases after
4 hours of consistent DSBs (Figure 3). The results of sfp1 survival, on the other hand,
generated more complicated results. While the average number of colony-forming units
per milliliter (CFU/mL) had decreased, there is a significant overlap among standard
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deviations between untreated and DSB-induced cells (Figure 3). Based on this
observation alone, we could conclude that the absence of Sfp1p slightly enhances the
DNA repair process, which contradicts the logic of our hypothesis. Considering the
previous data that suggests that Sfp1p is not required for standard HMO1 transcription,
cellular levels of Hmo1p should remain the same in sfp1 as in WT. Taken altogether,
the data suggests that Sfp1p may possibly be hindering DNA repair through other
biochemical pathways; in particular, its role in ribosome biogenesis may be producing
some effect that makes DSB repair more difficult.
2.00E+07
1.80E+07

1.60E+07

CFU/mL

1.40E+07
1.20E+07
1.00E+07
8.00E+06
6.00E+06
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0.00E+00
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WT

0 Hr

4 Hr

sfp1

Figure 3. Sfp1p’s Effects on DSB Survival. Bar graph representing the quantification of
calculated CFU/mL of culture between WT and sfp1 cells before galactose treatment (0
Hr) and after 4 hours of DSB induction via galactose (4 Hr). Means and standard
deviations are representative of 2 (WT) and 4 (sfp1) replicates.
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3.2. mTORC1 is Likely Inducing mRNA Degradation During Stress
As mentioned above, mTORC1 inhibition, whether through rapamycin-treatment
or stress, leads to a reduction in HMO1 transcript levels. Our lab has previously
demonstrated an eviction of Pol ll throughout the HMO1 gene shortly after inducing
mTORC1 inhibition, initially providing a possible explanation for the transcript decrease.
However, preliminary data later suggested that the same Pol ll eviction occurs in tor1
cells, where HMO1 transcripts remain high, suggesting that the decrease in transcript
levels is not simply the result of the removal of Pol ll (Figure 4A). In order to verify this
finding, multiple replicates of ChIP were performed using an anti-Pol ll antibody to
measure occupancy along the HMO1 ORF in a tor1 strain. As expected, Pol ll-binding
was attenuated over time, with high significance (p<0.05) at the 60-minute mark (Figure
4B and 4C).
These observations highly suggest that the relative amounts of HMO1 transcripts
during DSBs is dependent on the presence or absence of mTORC1 rather than Pol ll.
One possible explanation is that mTORC1 is actively participating in transcript
degradation. This is likely the case, as previous studies have demonstrated a similar
function at other genes: Talarek, et al. demonstrated that mTORC1 uses the Rim15Igo1/2-PP2ACdc55 effector branch to manage the stability of transcripts that come from
genes that use Msn2p/Msn4p and Gis1p as transcription factors (6), while Albig and
Decker had shown that mTORC1-mediated degradation of certain mRNAs through
deadenylation/reduced adenylation and decapping (7). Interestingly, mTORC1 has also
been found to be a negative regulator of exosome release in mouse embryo fibroblasts,
thus suggesting a possibility of exosome-enclosed mRNA regulation (29). The role of
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mRNA degradation by mTORC1 may be justified by two possible theories. First, the cell
may prefer to allocate the energy used during the gene translation process to that of DNA
repair. Second, the cell realizes that high levels of Hmo1p would hinder the DNA repair
process, and so it degrades its own HMO1 transcripts to prevent an accumulation of
Hmo1p within the cell (2,3,8; Figure 3).

A

C

B

Figure 4. Pol ll is Evicted from HMO1 During DSBs. (A) Simplified visual model of the
effects of DSBs on HMO1 transcription in the presence (top) and absence (bottom) of
mTORC1 signaling. (B) Gel images representing one replicate of ChIP performed at
the HMO1 promoter in tor1 using the Pol ll antibody (IC = Input Control; NA = No
Antibody Sample; IP = Antibody-Immunoprecipitated Sample). (C) Graphical data
representing the relative ImageJ-quantified band intensities of standardized IP bands
over the course of 60 minutes (Min). Means and standard deviations are
representative of 3 (0, 15, and 30 Min) and 2 (60 Min) replicates. p < 0.05 determined
by Student’s t-test.
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CHAPTER 4. CONCLUSION AND FUTURE DIRECTIONS
Hmo1p is an important component of both gene transcription and chromatin
stability, and our experiments here further emphasize this. First, we show how the
transcription factor Sfp1p is somehow involved in the biochemical pathway leading to
HMO1 regulation. More specifically, it is likely a factor in relaying the mTORC1 stress
signal to the promoter. As our wide range of OD600 readings seems to have been the
cause of the wide error bars around the sfp1 means (Figures 2A and 2C), redoing the
experiment with narrower cell concentration limits is advised in order to determine Sfp1p’s
precise role in HMO1 regulation. In addition, its presence may be a hinderance to DSB
repair, although the means by which it is are unclear. Considering its role in binding to RP
promoters as a means of activation, it is possible that Sfp1p could be doing the same
thing at the HMO1 promoter; therefore, we propose generating a FLAG-tagged Sfp1p
strain in order to determine this phenomenon via ChIP. Furthermore, Western Blotting
can be used to test the previously-stated hypothesis that there should be no difference in
cellular Hmo1p concentrations between WT and sfp1 strains. In addition, predicted
binding sites within the HMO1 promoter (5) suggest the possibility of Reb1p being
involved in transcription regulation. In particular, Reb1p is evicted from the HMO1 gene
during an overaccumulations of Hmo1p (5), which generates a negative-feedback
response on its own promoter (5,14), pointing to the possibility of Reb1p being a
transcriptional activator.
Second, we demonstrated that Pol ll is evicted from the HMO1 gene during stress
regardless of whether Tor1p is present. Since we used only ORF-spanning primers, it is
suggested that this experiment be redone using primers spanning the HMO1 promoter
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region in order to validate that Pol ll is either being evicted at the transcription preinitiation
complex or failing to reach the promoter altogether. Considering that HMO1 transcript
levels are significantly reduced during DSB only when Tor1p is present, we propose that
mTORC1 may be playing a role in HMO1 transcript degradation during stress. In order to
test this hypothesis, we suggest using actinomycin D to halt the transcription process in
both WT and tor1 cells. Actinomycin D is a commonly used transcriptional inhibitor that
stabilizes the covalent bonds formed between topoisomerase I and DNA by intercalating
into GC-rich sequences. As a result, Pol ll will be stopped during the mRNA synthesis
process, ultimately leading to transcriptional failure (15). After collecting a 0-hour control
and adding actinomycin D, transcripts can be extracted and quantified in order to
determine the difference in mRNA half-lives between the two strains. Previous studies
have established how mTORC1’s roles may go beyond signal transduction, and that all
of these activities interplay to keep cellular metabolism in check. These findings may
therefore have some medical significance, as faulty mTORC1 activity in mammals have
been shown to be involved in diseases, particularly cancer.
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